clinically dead
US biotech company to try resurrect the clinically dead
May 4, 2016Research and Development US, bioquark, biotech, brain, central nervous system, clinically dead, dead, patients, ressurect
A US biotech firm has announced plans for a Phase I trial that will see them attempt to bring brain-dead …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
